Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders
NCT ID: NCT02067546
Last Updated: 2014-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Its efficacy will be evaluated in the current study, on 50 volunteers who suffer from constipation and meet the Rome 3 criteria for constipation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Interferential Therapy in Chronic Constipation (CON-COUR)
NCT02381665
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
NCT02030756
Evaluation of Prucalopride in Male Subjects With Chronic Constipation.
NCT01147926
Use of a Squatting Assist Device in Patients With Constipation
NCT02877394
Comparison of Two Methods for Bowel Preparation in Patients With Constipation
NCT03306030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Company " Shva-Nach" Ltd. and its design team designed a seat at an angle slightly elevated and a toilet stool customized to the personal anatomy of each subject.
The purpose of the study: evaluating efficacy elevated toilet seat with a support of a brackets stool making emptying easier in patients with constipation and difficulty in emptying.
Methods: An open, randomized, crossover study in use of a toilet seat and comparing it to a standard seat.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental toilet seat
Experimental toilet seat for 1 month
Experimental toilet seat
Standard toilet seat
Standard toilet seat for 1 month
Standard toilet seat
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental toilet seat
Standard toilet seat
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age group 18-80 years
3. Study population may include patients suffering from metabolic diseases such as diabetes mellitus, hypothyroidism and hypercalcemia.
4. Patients who understand the goals of the research and collaborate
Exclusion Criteria
2. women with known pregnancy - second trimester and up
3. Patients with obesity - BMI\> 35 and / or weight over 120 kg
4. Neurological diseases - dementia, Parkinson's disease, CVA, multiple sclerosis, muscular dystrophy, spinal cord injury
5. Disabled patients on wheelchairs.
6. Patients with active anal fissure / fistula, active inflammation of the colon, patients after resection of the colon.
7. Minors and no judgment
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-13-RY-244-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.